×
About 2,918 results
VENTANA PD-L1 (SP142) Assay - P160002/S009
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm633972.htm

Mar 10th, 2019 - What is it? It is a test done in a laboratory using samples from triple negative breast cancer patients which doctors use to see if patients have programmed cell death ligand (PD-L1) in their cancer. When is it used? To help doctors decide whether atezolizumab is the best treatment choice for their patients. Atezolizumab is a drug that blocks PD-L1. Doctors use atezolizumab in combination wi...

Sangia Total PSA Test - P170037
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm630197.htm

Jan 29th, 2019 - The Sangia Total Prostate Specific Antigen (PSA) Test consists of a Cassette Assembly and a Sample Collector. The Sangia Total PSA Test is used as an aid in the diagnosis of prostate cancer. This new test is the first point-of-care test that can deliver PSA results near where the patient is being evaluated, for example at the doctor's office, instead of waiting for lab analysis. The test can be...

Updated durvalumab monotherapy data confirm results in urothelial bladder cancer
https://www.astrazeneca.com/media-centre/press-releases/2017/updated-durvalumab-monotherapy-data-confirm-results-in-urothelial-bladder-cancer-17022017.html

Feb 16th, 2017 - AstraZeneca and its global biologics research and development arm, MedImmune, today announced updated efficacy and safety data for durvalumab in patients with locally-advanced or metastatic urothelial cancer (UC). Updated results from the Phase I/II trial, presented at the 2017 ASCO Genitourinary Cancers Symposium, showed an objective response rate (ORR) of 20.4% in all evaluable patients (n...

Axumin® (fluciclovine F 18)
https://www.axumin.com/

Learn about Axumin® (fluciclovine F 18) injection, a diagnostic imaging agent that can help detect and localize prostate cancer across local and distant sites of recurrence.

ELIGARD (leuprolide acetate for injectable suspension)
http://eligardhcp.com/

Official HCP Web site for ELIGARD, a palliative treatment for advanced prostate cancer. Please see Important Safety Information.

ELMIRON®-100 MG (PENTOSAN POLYSULFATE SODIUM)
https://www.orthoelmiron.com/hcp/home

Learn more about treatment with ELMIRON® (pentosan polysulfate sodium)

FLOMAX (tamsulosin HCl)
https://www.4flomax.com/

Flomax® (tamsulosin HCl) capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

EDEX® (alprostadil for injection)
https://edex.com/hcp.php

edex® (alprostadil for injection) prescription information. ... https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/UCM071436.pdf. Accessed ...

Detrol® LA (tolterodine tartrate extended release capsules)
https://www.pfizerpro.com/product/detrol-la/hcp

With DETROL LA Savings Cards, eligible patients may: Pay as little as $0 per monthly fill†; Save up to $150 per month—a savings of up to $1,800 a year ...

CEFTIN Tablets (cefuroxime axetil tablets)
https://gsksource.com/pharma/content/gsk/source/us/en/brands/ceftin.html

See full prescribing information for CEFTIN. CEFTIN (cefuroxime axetil) tablets, for oral use. CEFTIN (cefuroxime axetil) for oral suspension. Initial U.S. Approval: ...

FARR LAB PRODUCTS
http://www.farrlabs.com/?mm_campaign=437533dc58fa3d84df0551da2b913313&keyword=farr%20laboratories&gclid=Cj0KCQiAtJbTBRDkARIsAIA0a5OBr7FcPM2PnEJiMOcSLIlfS3oTtO6w9K-jeIbMQp4_XTQFhtLCqVYaAp6hEALw_wcB

Farr Labs is the premier manufacturer and distributor of nutraceuticals developed to address symptoms associated with chronic prostatitis, BPH, interstitial cystitis, and other conditions.

GLYDO® (lidocaine HCl jelly USP, 2%)
http://glydo.com/

GLYDO (lidocaine HCl jelly USP, 2%) is a sterile aqueous product that contains a local anesthetic agent and is administered topically. (See INDICATIONS for specific uses.) GLYDO (lidocaine HCl jelly USP, 2%) contains lidocaine HCl which is chemically designated as acetamide, 2-(diethyl-amino)-N-(2,6-dimethylphenyl)-, ...

PREGNYL®(chorionic gonadotropin for injection, USP)
https://www.merckconnect.com/pregnyl/overview.html

PREGNYL is indicated for the induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not ...

PREMARIN® (conjugated estrogens tablets, USP)
https://www.pfizerpro.com/product/premarin/hcp

Help patients save on PREMARIN® (conjugated estrogens tablets, USP), order ... of vulvar and vaginal atrophy, topical vaginal products should be considered.

Caverject Impulse® (alprostadil for injection)
https://www.pfizerpro.com/product/caverject-impulse/hcp

Prolonged erection and priapism have occurred in patients receiving CAVERJECT IMPULSE. To minimize the chances of this occurring, titrate CAVERJECT ...

CAVERJECT® IMPULSE (alprostadil) (alprostadil)
https://www.pfizermedicalinformation.com/en-us/caverject-impulse-alprostadil

CAVERJECT IMPULSE (alprostadil) medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the package insert, announcements, resources, and ways to connect with Pfizer Medical through a variety of channels.

FIRMAGON® (degarelix) INJECTION
https://firmagon.com/hcp/

Start testosterone suppression now with FIRMAGON® (degarelix), the GnRH receptor antagonist that lower testosterone by 88% on day 1.

JEVTANA® (cabazitaxel) INJECTION
https://www.jevtanapro.com/

Learn more about JEVTANA and how it may help your mCRPC (metastatic castration-resistant prostate cancer) patients. See risks and benefits.

Home | Yonsa
http://www.yonsarx.com/

Now Approved YONSA® in combination with methylprednisolone is now approved for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).